Targeted Anti-Cancer Drugs: DRUP Trial

We are studying how well existing targeted drugs work for patients with advanced cancers that have specific genetic markers. This trial aims to improve access to effective treatments and gather important data on their use.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Alecensa
Alecensa is a cancer medicine used to treat certain types of lung cancer caused by specific genetic changes.
Avastin
Avastin is a cancer medicine used to slow tumor growth by stopping tumors from getting new blood vessels.
Cabometyx
Cabometyx is a cancer medicine used to treat certain advanced kidney and liver cancers.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Abemaciclib
Abemaciclib is a substance that slows growth of certain breast cancer cells by blocking proteins that help them divide.
Alectinib Hydrochloride
Alectinib hydrochloride is a substance that targets lung cancers with an ALK gene change to slow tumor growth and spread.
Alpelisib
Alpelisib is a substance that targets a cancer growth pathway to treat certain breast cancers with specific gene mutations.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Perjeta
Mekinist
Rubraca

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Abevmy
Aksitinib Alpha-Medical
Aksitinib Sandoz

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Academisch Medisch Centrum
Oncology
Abcoude, Netherlands
Noordwest Ziekenhuisgroep Stichting
Medical Oncology
Alkmaar, Netherlands
Ziekenhuisgroep Twente Stichting
Internal Medicine and Gastrointestinal liver disease
Almelo, Netherlands

Sponsor: Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.